Evaluate the effect of TECAR therapy on pain, voiding, erectile function, sleep quality and quality of life in men with chronic prostatitis/chronic pelvic pain syndrome.
Presence of chronic prostatitis/chronic pelvic pain symptoms for more than 6 months.
Ages will be ranged from 30 to 50 years old.
Urinary and seminal infections.
Recent parenteral steroid administration.
Prior prostate or pelvic surgery.
Lower urinary tract disorders such as bladder stones.
Parallel
TECAR therapy
DeviceWINBACK 3SE (France) will be used for TECAR therapy in this study. To facilitate optimal distribution of endogenous heat therapy and effective contact between the active electrodes, both capacitive and resistive, and the surface of the skin, a layer of high-conductivity cream will be applied to the treatment region. The plate, an inactive electrode, which has a specific size (21cm\*15cm), will be placed on the gluteal region. The capacitive electrode was employed for a duration of seven and a half minutes, at an intensity of 30-40%, whereas the resistance electrode will be utilized for an equivalent period over the perineum at the same intensity.
Sham TECAR therapy
DeviceThe procedure is similar to the active treatment of TECAR, but with the critical difference being that the output intensity of the TECAR device will be set to zero during the session.
Pelvic pain
Pain will be assessed using the National Institutes of Health-Chronic Prostatitis Symptom Index
Quality of life of men
Quality of life will be assessed using the National Institutes of Health-Chronic Prostatitis Symptom Index
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options:
